Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

Table 2

Patient characteristics.

Median age 50 years (range 34–75)	Patients (𝑛=24) 𝑛 (%)
Sex
Male	13 (54.2)
Female	11 (45.8)
Sites of evaluable disease
Viscera	20
Bone	1
Soft tissue	14
Lymph nodes	13
Previous treatments
BioT	1
BioCT	12
CT	7
RT	3
No treatment	3